High-resolution cryo-EM analysis of a Streptococcus pyogenes M-protein/human plasminogen complex

Bradley M Readnour1, Sheiny Tjia-Fleck1, Nathan R McCann1

  • 1W.M. Keck Center for Transgene Research, University of Notre Dame, Notre Dame, IN 46556, USA; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.

PubMed

Insights

Group A Streptococcus bacteria use PAM receptors to bind human plasminogen (hPg), aiding cell invasion. This study reveals the compact structure of this complex on cell surfaces, offering targets for new treatments.

Area of Science:

  • Microbiology
  • Structural Biology
  • Biochemistry

Background:

  • Cellular invasiveness is crucial for pathogens like Group A Streptococcus (GAS).
  • GAS utilizes cell surface receptors to bind human plasminogen (hPg) and human plasmin (hPm), facilitating invasion.
  • Understanding the structure of these receptor-ligand complexes is key to developing therapeutics.

Purpose of the Study:

  • To determine the high-resolution structure of a Group A Streptococcus (GAS) bacterial receptor (PAM) bound to its ligand, human plasminogen (hPg).
  • To investigate the structural conformation of the PAM-type M-Protein (M-Prt) ectodomain when complexed with hPg on a cell surface.

Main Methods:

  • Engineered lentivirus (LV) particles expressing PAM as a model cell surface.
  • High-resolution structural analysis of the M-Prt ectodomain in complex with hPg.

Main Results:

  • The M-Prt ectodomain, when bound to hPg on the cell surface, adopts a more compact folded structure.
  • Distinct intra- and inter-domain interactions stabilize this compact conformation.
  • This reveals a new structural paradigm for membrane-bound M-Prt/ligand complexes.

Conclusions:

  • The structural insights into the GAS PAM-hPg complex provide a molecular framework for understanding virulence.
  • This work lays the foundation for developing novel therapeutic strategies against GAS infections.
  • Targeting these virulence-determining membrane proteins offers a promising avenue for treatment development.